Much of that debate has centered around the safety of sterile-injectable drug compounding, with the quality of active pharmaceutical ingredient (API) or bulk that pharmacies use to compound receiving much less attention
(1) Controlled-Release PHEN/TPM in Severely Obese Adults (EQUIP) trial (obesity without comorbidities), (2) Controlled-Release Phentermine plus Topiramate Combination in Overweight and Obese Adults (CONQUER) trial (obesity with comorbidities), and (3) SEQUEL (2-year extension of CONQUER), were comprised of 7% of older adult participants across the trials, although the upper age limit was 70 [111,112,113]
Micronutrient supplements: toxicity and drug interactions
If you are unsure how those unit marks map to volume, our insulin syringe units guide walks through it
Ultimately, integrating multimodal biomarkerscombining neuroimaging, electrophysiology (Cardon et al., 2020), blood-based molecular profiles, and audiological measuresinto a composite model holds the greatest promise